AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea
· Delayed Price · Currency is KRW
7,410.00
+380.00 (5.41%)
Jan 22, 2025, 3:00 PM KST
AptaBio Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Jan '25 Jan 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 199,460 | 201,805 | 237,483 |
| Market Cap Growth | -5.61% | -15.02% | - |
| Enterprise Value | 175,171 | 152,862 | - |
| Last Close Price | 7420.00 | 9050.00 | 10650.00 |
| Forward PE | - | 78.10 | 78.10 |
| PS Ratio | 57.43 | 623.11 | 4911.46 |
| PB Ratio | 3.75 | 3.29 | 4.53 |
| P/TBV Ratio | 3.99 | 3.32 | 4.54 |
| EV/Sales Ratio | 60.28 | 471.99 | - |
| Debt / Equity Ratio | 0.28 | 0.23 | 0.01 |
| Asset Turnover | 0.03 | 0.00 | - |
| Quick Ratio | 2.26 | 65.10 | 16.58 |
| Current Ratio | 2.50 | 70.27 | 19.63 |
| Return on Equity (ROE) | -35.92% | -21.21% | - |
| Return on Assets (ROA) | -13.50% | -14.22% | - |
| Return on Capital (ROIC) | -17.31% | -16.50% | - |
| Earnings Yield | -12.09% | -5.98% | -4.45% |
| FCF Yield | -8.57% | -7.65% | -3.32% |
| Buyback Yield / Dilution | -0.84% | -0.05% | - |
| Total Shareholder Return | -0.84% | -0.05% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.